LOGIN  |  REGISTER
Amneal Pharmaceuticals

Recent Insider Transactions - Vir Biotechnology (NASDAQ: VIR)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ VIR Vir Biotechnology
De Backer Marianne / director, officer: Chief Executive Officer
04/03/2025
Sell
$5.95
79,712
$474K
769,505
NASDAQ VIR Vir Biotechnology
de Verneuil Vanina / officer: EVP and General Counsel
02/26/2025
Sell
$9.14
7,373
$67K
79,460
NASDAQ VIR Vir Biotechnology
SCANGOS GEORGE A / director
02/24/2025
Sell
$9.45
10,056
$95K
698,239
NASDAQ VIR Vir Biotechnology
HANLY ANN M. / officer: EVP & Chief Technology Officer
02/24/2025
Sell
$9.45
14,168
$134K
117,901
NASDAQ VIR Vir Biotechnology
O'Byrne Jason / officer: EVP & Chief Financial Officer
02/22/2025
Buy
$9.57
80,000
$766K
80,000
NASDAQ VIR Vir Biotechnology
Eisner Mark / officer: EVP and Chief Medical Officer
02/22/2025
Buy
$9.57
80,000
$766K
80,000
NASDAQ VIR Vir Biotechnology
Sabatini Brent / officer: SVP, Chief Accounting Officer
02/24/2025
Sell
$9.45
1,562
$15K
46,627
NASDAQ VIR Vir Biotechnology
Sabatini Brent / officer: SVP, Chief Accounting Officer
02/22/2025
Buy
$9.57
40,000
$383K
40,000
NASDAQ VIR Vir Biotechnology
De Backer Marianne / director, officer: Chief Executive Officer
02/24/2025
Sell
$9.45
16,122
$152K
849,217
NASDAQ VIR Vir Biotechnology
De Backer Marianne / director, officer: Chief Executive Officer
02/22/2025
Buy
$9.57
480,000
$4.594M
480,000
NASDAQ VIR Vir Biotechnology
de Verneuil Vanina / officer: EVP and General Counsel
02/24/2025
Sell
$9.45
5,140
$49K
86,833
NASDAQ VIR Vir Biotechnology
de Verneuil Vanina / officer: EVP and General Counsel
02/22/2025
Buy
$9.57
70,000
$670K
70,000